Reduced Density of Calbindin Immunoreactive GABAergic Neurons in the Occipital Cortex in Major Depression: Relevance to Neuroimaging Studies

Biological Psychiatry

Volumn 67, Issue 5, 2010, Pages 465-470

  Maciag, Dorota ^a   Hughes, Jonathan ^a   O'Dwyer, Gillian ^a   Pride, Yilianys ^a   Stockmeier, Craig A ^a,c   Sanacora, Gerard ^b   Rajkowska, Grazyna ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Calbindin immunoreactivity; GABAergic neurons; major depression; occipital cortex; postmortem

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALBINDIN;

ADULT; AGED; ARTICLE; BRAIN NERVE CELL; CADAVER; CELL DENSITY; CELL SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GABAERGIC SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INTERNEURON; MAJOR DEPRESSION; MALE; NEUROIMAGING; NEUROPATHOLOGY; OCCIPITAL CORTEX; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; MIDDLE AGED; OCCIPITAL LOBE; RECEPTORS, GABA; YOUNG ADULT;

EID: 75849156656     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.10.027     Document Type: Article

References (28)

1. Sanacora G., and Saricicek A. GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action. CNS Neurol Disord Drug Targets 6 (2007) 127-140
2. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A., et al. Reduced cortical γ-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56 (1999) 1043-1047
3. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.-T., Appel M., Rothman D.L., and Krystal J.H. Subtype-specific alterations of GABA and glutamate in major depression. Arch Gen Psychiatry 61 (2004) 705-713
4. Hasler G., van der Veen J.W., Tumonis T., Meyers N., Shen J., and Drevets W.C. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64 (2007) 193-200
5. Bhagwagar Z., Wylezinska M., Jezzard P., Evans J., Ashworth F., Sule A., and Cohen P.J. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry 61 (2007) 806-812
6. Price R.B., Shungu D.C., Mao X., Nestadt P., Kelly C., Collins K.A., et al. Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: Relationship to treatment resistance in major depressive disorder. Biol Psychiatry 65 (2009) 792-800
7. Petty F. GABA and mood disorders: A brief review and hypothesis. J Affect Disord 34 (1995) 275-281
8. Rajkowska G., O'Dwyer G., Teleki Z., Stockmeier C.A., and Miguel-Hidalgo J.J. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 32 (2007) 471-482
9. Karolewicz B., Maciag D., O'Dwyer G., Stockmeier C.A., and Rajkowska G. Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression. (published online ahead of print September 15). Int J Neuropsychopharmacol (2009) doi: 10.1017/S1461145709990587:1-10
10. Gos T., Günther K., Bielau H., Dobrowolny H., Mawrin C., Trübner K., et al. Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-immunorective neuropil. J Affect Disord 113 (2009) 45-55
11. Fatemi S.H., Stary J.M., Earle J.A., Araghi-Niknam M., and Eagan E. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr Res 72 (2005) 109-122
12. Rajkowska G., Miguel-Hidalgo J.J., Wei J., Dilley G., Pittman S.D., Meltzer H.Y., et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45 (1999) 1085-1098
13. Spitzer R.L., and Endicott J. Schedule for Affective Disorders and Schizophrenia (SADS). 3rd ed. (1978), New York State Psychiatric Institute, New York
14. First M.B., Donovan S., and Frances A. Nosology of chronic mood disorders. Psychiatr Clin North Am 19 (1996) 29-39
15. Deep-Soboslay A., Akil M., Martin C., Bigelow L., Herman M., Hyde T., and Kleinman J. Reliability of psychiatric diagnosis in postmortem research. Bioll Psychiatry 57 (2005) 96-101
16. Kelly T.M., and Mann J.J. Validity of DSM-III-R diagnosis by psychological autopsy: A comparison with clinician ante-mortem diagnosis. Acta Psychiatr Scand 94 (1996) 337-343
17. McGirr A., Renaud J., Seguin M., Alda M., Benkelfat C., Lesage A., and Turecki G. An examination of DSM-IV depressive symptoms and risk for suicide completion in major depressive disorder: A psychological autopsy study. J Affect Disord 97 (2007) 203-209
18. Miguel-Hidalgo J.J., and Rajkowska G. Immunohistochemistry of neural markers for the study of the laminar cytoarchitecture in celloidin sections from the human cerebral cortex. J Neurosci Methods 93 (1999) 69-79
19. Mason G.F., Petrakis I.L., de Graaf R.A., Gueorguieva R., Guidone E., Coric V., et al. Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: Preliminary evidence of modification by cigarette smoking. Biol Psychiatry 59 (2006) 85-93
20. Satta R., Maloku E., Zhubi A., Pibiri F., Hajos M., Costa E., and Guidotti A. Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons. Proc Natl Acad Sci U S A 105 (2008) 16356-16361
21. Benes F.M., and Berretta S. GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 50 (2001) 395-406
22. Friberg T.R., and Borrero G. Diminished perception of ambient light: A symptom of clinical depression?. J Affect Disord 61 (2000) 113-118
23. Vasile R.G., Duffy F.H., McAnulty G., Mooney J.J., Bloomingdale K., and Schildkraut J.J. Abnormal flash visual evoked response in melancholia: A replication study. Biol Psychiatry 31 (1992) 325-336
24. Coullaut-Valera García J., Arbaiza Díaz del Rio I., Coullaut-Valera García R., and Ortiz T. Alterations of P300 wave in occipital lobe in depressive patients. Actas Esp Psiquiatr 35 (2007) 243-248
25. Normann C., Schmitz D., Fürmaier A., Döing C., and Bach M. Long-term plasticity of visually evoked potentials in humans is altered in major depression. Biol Psychiatry 62 (2007) 373-380
26. Bubl E., Van Elst L.T., Gondan M., Ebert D., and Greenlee M.W. Vision in depressive disorder. World J Biol Psychiatry 12 (2007) 1-8
27. Golomb J.D., McDavitt J.R.B., Ruf B.M., Chen J.I., Saricicek A., Maloney K.H., et al. Enhanced visual motion perception in major depressive disorder. J Neurosci 29 (2009) 9072-9077
28. Hasler G., Fromm S., Alvarez R.P., Luckenbaugh D.A., Drevets W.C., and Grillon C. Cerebral blood flow in immediate and sustained anxiety. J Neurosci 27 (2007) 6313-6319